Mesoporous silica-based nanoplatforms are theranostic agents for the treatment of inflammatory disorders

HIGHLIGHTS

  • who: Bhagavathi Sundaram Sivamaruthi and collaborators from the Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand have published the paper: Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders, in the Journal: Pharmaceutics 2023, 15, x FOR PEER REVIEW of /2023/
  • what: This approach has been practiced against chronic neurological diseases such as Huntington`s and Rett`s syndrome . This study provides an overview of the types, synthesis, mechanisms of formation, properties, and functionalization of MSNs, and emphasizes MSNs as a theranostic tool for inflammatory diseases. The study showed . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?